NRXP
Price
$3.84
Change
-$0.08 (-2.04%)
Updated
Jun 12 closing price
Capitalization
164.35M
64 days until earnings call
Intraday BUY SELL Signals
TCRX
Price
$0.91
Change
-$0.01 (-1.09%)
Updated
Jun 12 closing price
Capitalization
59.61M
66 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NRXP vs TCRX

Header iconNRXP vs TCRX Comparison
Open Charts NRXP vs TCRXBanner chart's image
NRXP vs TCRX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
NRXP vs. TCRX commentary
Jun 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRXP is a Hold and TCRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 14, 2026
Stock price -- (NRXP: $3.84 vs. TCRX: $0.91)
Brand notoriety: NRXP and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRXP: 43% vs. TCRX: 43%
Market capitalization -- NRXP: $164.35M vs. TCRX: $59.61M
NRXP [@Biotechnology] is valued at $164.35M. TCRX’s [@Biotechnology] market capitalization is $59.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $112.92B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRXP’s FA Score shows that 0 FA rating(s) are green whileTCRX’s FA Score has 1 green FA rating(s).

  • NRXP’s FA Score: 0 green, 5 red.
  • TCRX’s FA Score: 1 green, 4 red.
According to our system of comparison, NRXP is a better buy in the long-term than TCRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRXP’s TA Score shows that 4 TA indicator(s) are bullish while TCRX’s TA Score has 4 bullish TA indicator(s).

  • NRXP’s TA Score: 4 bullish, 5 bearish.
  • TCRX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both NRXP and TCRX are a bad buy in the short-term.

Price Growth

NRXP (@Biotechnology) experienced а -7.25% price change this week, while TCRX (@Biotechnology) price change was -7.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.78%. For the same industry, the average monthly price growth was +90.18%, and the average quarterly price growth was +2050.65%.

Reported Earning Dates

NRXP is expected to report earnings on Aug 17, 2026.

TCRX is expected to report earnings on Aug 19, 2026.

Industries' Descriptions

@Biotechnology (+0.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRXP($164M) has a higher market cap than TCRX($59.6M). NRXP YTD gains are higher at: 41.697 vs. TCRX (-8.790). NRXP has higher annual earnings (EBITDA): -23.33M vs. TCRX (-118.65M). TCRX has more cash in the bank: 128M vs. NRXP (6.71M). NRXP has less debt than TCRX: NRXP (934K) vs TCRX (92.5M). TCRX has higher revenues than NRXP: TCRX (9.14M) vs NRXP (2.29M).
NRXPTCRXNRXP / TCRX
Capitalization164M59.6M275%
EBITDA-23.33M-118.65M20%
Gain YTD41.697-8.790-474%
P/E Ratio0.36N/A-
Revenue2.29M9.14M25%
Total Cash6.71M128M5%
Total Debt934K92.5M1%
FUNDAMENTALS RATINGS
NRXP: Fundamental Ratings
NRXP
OUTLOOK RATING
1..100
85
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
92
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NRXPTCRX
RSI
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
82%
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 20 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
87%
Aroon
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
NRXP
Daily Signal:
Gain/Loss:
TCRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PCVAX13.530.18
+1.35%
Virtus NFJ Small-Cap Value A
ALVOX139.260.95
+0.69%
Alger Capital Appreciation Ptfl I-2
LAVPX16.760.10
+0.60%
Lord Abbett Fundamental Equity P
AILIX13.950.04
+0.29%
Cavanal Hill Hedged Equity Income Instl
MIGFX39.990.09
+0.23%
MFS Massachusetts Inv Gr Stk A

NRXP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXP has been closely correlated with TAOX. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRXP jumps, then TAOX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXP
1D Price
Change %
NRXP100%
-2.04%
TAOX - NRXP
84%
Closely correlated
-5.24%
ALLR - NRXP
81%
Closely correlated
-7.74%
PALI - NRXP
74%
Closely correlated
-3.93%
BOLT - NRXP
32%
Poorly correlated
-4.40%
TCRX - NRXP
32%
Poorly correlated
-1.28%
More

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with MGX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then MGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
-1.28%
MGX - TCRX
45%
Loosely correlated
-4.00%
BCYC - TCRX
43%
Loosely correlated
-1.22%
SANA - TCRX
41%
Loosely correlated
-3.25%
PCVX - TCRX
40%
Loosely correlated
+0.36%
KURA - TCRX
39%
Loosely correlated
+2.14%
More